These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 31733607)

  • 1. B cell targeted therapies in autoimmune disease.
    Barnas JL; Looney RJ; Anolik JH
    Curr Opin Immunol; 2019 Dec; 61():92-99. PubMed ID: 31733607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell-Directed Therapy in Autoimmunity.
    Abeles I; Palma C; Meednu N; Payne AS; Looney RJ; Anolik JH
    Annu Rev Immunol; 2024 Jun; 42(1):103-126. PubMed ID: 38011889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and immunobiology of IL-21 in autoimmunity.
    Long D; Chen Y; Wu H; Zhao M; Lu Q
    J Autoimmun; 2019 May; 99():1-14. PubMed ID: 30773373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B Cell Metabolism and Autophagy in Autoimmunity.
    Raza IGA; Clarke AJ
    Front Immunol; 2021; 12():681105. PubMed ID: 34163480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B cell immunobiology in disease: evolving concepts from the clinic.
    Martin F; Chan AC
    Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders.
    Levesque MC
    Clin Exp Immunol; 2009 Aug; 157(2):198-208. PubMed ID: 19604259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases?
    Gianchecchi E; Delfino DV; Fierabracci A
    Front Immunol; 2021; 12():616853. PubMed ID: 33679757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
    Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
    Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cells as target for immunotherapy in rheumatic diseases - current status.
    Bryl E
    Immunol Lett; 2021 Aug; 236():12-19. PubMed ID: 34077805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases-Implications for Therapeutic Approaches.
    Fetter T; Niebel D; Braegelmann C; Wenzel J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33297481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of B cells in murine lupus: efficacy and resistance.
    Ahuja A; Shupe J; Dunn R; Kashgarian M; Kehry MR; Shlomchik MJ
    J Immunol; 2007 Sep; 179(5):3351-61. PubMed ID: 17709552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-lymphocyte contributions to human autoimmune disease.
    Yanaba K; Bouaziz JD; Matsushita T; Magro CM; St Clair EW; Tedder TF
    Immunol Rev; 2008 Jun; 223():284-99. PubMed ID: 18613843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses.
    Ettinger R; Karnell JL; Henault J; Panda SK; Riggs JM; Kolbeck R; Sanjuan MA
    Autoimmunity; 2017 Feb; 50(1):25-36. PubMed ID: 28166684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B Cells as a Therapeutic Target in Paediatric Rheumatic Disease.
    Wilkinson MGL; Rosser EC
    Front Immunol; 2019; 10():214. PubMed ID: 30837988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases.
    Burbano C; Villar-Vesga J; Vásquez G; Muñoz-Vahos C; Rojas M; Castaño D
    Front Immunol; 2019; 10():2058. PubMed ID: 31555283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell targeted therapies in autoimmune diseases.
    Isenberg DA
    J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial and functional heterogeneity of follicular helper T cells in autoimmunity.
    Seth A; Craft J
    Curr Opin Immunol; 2019 Dec; 61():1-9. PubMed ID: 31374450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity as the trigger of systemic autoimmune diseases.
    Saferding V; Blüml S
    J Autoimmun; 2020 Jun; 110():102382. PubMed ID: 31883831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.